Precision surgery, powered by prediction: Optimizing patient care with the best risk scores

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Risk prediction models are an important part of assessing operative mortality and postoperative complication rates in current cardiac surgery practice.

Amgen acquires Horizon Therapeutics for $27.8bn

The latest acquisition will bolster the inflammation portfolio of Amgen. Credit: Marlon Trottmann/Shutterstock.com. Amgen has acquired Ireland-based biotechnology company Horizon Therapeutics in a $27.8bn (£22.76bn)

October 9, 2023

With $5B in China sales, AstraZeneca doubles down on Chinese biopharma innovation

CAMBRIDGE, UK — AstraZeneca said it will continue to be the conduit for sharing Chinese innovation with the rest of the world, but will establish

May 22, 2024

PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMA | Psychedelic Invest

TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of

October 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.